Ian Chan

Ian Chan is the co-founder and CEO of Abpro, a biotechnology company aimed to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Ian has been with Abpro since its inception in 2007, when he and his brother Eugene founded the company. Ian received an AB from Brown University and MBA from Harvard University.

Posts by Ian Chan

MedCity Influencers

Funding to Improve Drug Availability

Government funding plays a major role in the advancement of drugs, including monoclonal antibodies, which are extremely expensive to produce and can take months to develop.

Monoclonal antibodies are the way out of the Covid-19 pandemic

Whether they are acting as a therapeutic or preventive treatment, monoclonal antibodies can allow us to help contain the virus, where we might see the light at the end of the tunnel.

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.